# Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness

> **NCT00573950** · PHASE4 · UNKNOWN · sponsor: **Korea University Anam Hospital** · enrollment: 48 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Metabolic Syndrome X

## Interventions

- **DRUG:** cilostazol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00573950
- **Lead sponsor:** Korea University Anam Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-12
- **Primary completion:** —
- **Final completion:** 2008-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2007-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00573950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00573950, "Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00573950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*